//periodicos.unisa.br/index.php/direitosaude <p data-start="137" data-end="575">A <strong data-start="139" data-end="213">Revista de Direito da Saúde Comparado (Comparative Health Law Journal)</strong> é uma publicação eletrônica internacional de fluxo contínuo, com <strong data-start="279" data-end="317">chamada permanente para submissões</strong> e organização de <strong data-start="335" data-end="358">duas edições anuais</strong>. Seu objetivo é difundir pesquisas e reflexões de professores e pesquisadores da área do Direito e da Saúde de todo o mundo. A revista é organizada no âmbito do Mestrado em Direito Médico da Universidade Santo Amaro.</p> <p data-start="577" data-end="854">A missão do periódico é promover o enriquecimento do debate científico e acadêmico, bem como disseminar amplamente pesquisas de qualidade, tanto em abordagens teóricas quanto empíricas, sobre direito médico, direitos fundamentais sociais de saúde e políticas públicas em saúde.</p> <p data-start="856" data-end="1073">A revista segue uma linha editorial ampla e adota rigorosos critérios estabelecidos pela CAPES, com avaliação por <em>double blind review</em>, assegurando a imparcialidade na análise dos trabalhos submetidos e publicados.</p> Universidade Santo Amaro (UNISA) pt-BR Revista de Direito da Saúde Comparado 2965-4912 //periodicos.unisa.br/index.php/direitosaude/article/view/1333 <p>The paper to follow examines what constitutes legal medicine and medical/health law to consider and compare their role in the delivery of health care and justice. It explores an overview of the changes that have impacted legal medicine in the 21st Century with a particular focus on the contributions of both telemedicine, especially since the Covid Pandemic, and the emerging role of artificial intelligence. It has highlighted the positives and negatives of both of these concepts and how they have influenced the evolution of medical care within the community. It touches upon the move to patient-centred medicine and examines how technology has empowered patients to anticipate the care provided while concurrently empowering them to more proactive litigation. This has been further enhanced by the Australia approach to ‘no win/no pay’ litigation in which the Plaintiff does not face immense costs should litigation fail. It also examines the clarification of what constitutes proper professional care, within the Australian context. It explores the move from the Bolam Principle which dominated, until the end of the last century, to the establishment of greater certainty in which the Courts decide what must be imparted to the patient, to allow true informed consent/refusal, and what constitutes proper medical care which is the purvey of the medical profession.</p> Roy G Beran Copyright (c) 2026 Revista de Direito da Saúde Comparado https://creativecommons.org/licenses/by-nc/4.0 2026-10-23 2026-10-23 5 9 03 10 //periodicos.unisa.br/index.php/direitosaude/article/view/1334 <p>Les médicaments connectés constituent une innovation technologique dans le domaine de la santé, notamment pour le traitement des troubles psychiatriques. Toutefois, leur utilisation soulève d'importantes questions juridiques relatives à la protection des données personnelles et au respect des droits des patients. Cet article examine les fondements juridiques permettant de garantir la licéité du traitement des données de santé conformément aux articles 6 et 9 du Règlement général sur la protection des données (RGPD). Il met en évidence les limites du consentement comme base légale, particulièrement lorsque les patients présentent des troubles psychiatriques susceptibles d'affecter leur liberté de décision. L'analyse souligne l'importance de l'intérêt légitime du médecin et du patient, ainsi que des garanties nécessaires à la protection des personnes concernées, notamment le droit d'opposition, l'information préalable et le consentement aux soins. Elle distingue également le consentement à l'acte médical du fondement juridique du traitement des données personnelles. Enfin, l'étude aborde les enjeux liés à la sécurité des objets connectés, à la prévention des risques de violation des données et à la nécessité de renforcer les mesures de protection. Elle souligne ainsi l'importance de concilier innovation médicale, sécurité des données et respect des droits fondamentaux des patients.</p> Cyril Aufrechter Copyright (c) 2026 Revista de Direito da Saúde Comparado https://creativecommons.org/licenses/by-nc/4.0 2026-10-23 2026-10-23 5 9 11 12